0001493152-22-033918.txt : 20221129 0001493152-22-033918.hdr.sgml : 20221129 20221129160515 ACCESSION NUMBER: 0001493152-22-033918 CONFORMED SUBMISSION TYPE: DEFA14A PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 20221129 DATE AS OF CHANGE: 20221129 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Biofrontera Inc. CENTRAL INDEX KEY: 0001858685 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473765675 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEFA14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-40943 FILM NUMBER: 221432803 BUSINESS ADDRESS: STREET 1: 120 PRESIDENTIAL WAY, STREET 2: SUITE 330 CITY: WOBURN STATE: MA ZIP: 01801 BUSINESS PHONE: 781-245-1325 MAIL ADDRESS: STREET 1: 120 PRESIDENTIAL WAY, STREET 2: SUITE 330 CITY: WOBURN STATE: MA ZIP: 01801 DEFA14A 1 formdefa14a.htm

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

SCHEDULE 14A

PROXY STATEMENT

 

PURSUANT TO SECTION 14(a) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐

 

Check the appropriate box:

 

Preliminary Proxy Statement
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
Definitive Proxy Statement
Definitive Additional Materials
Soliciting Material Pursuant to Section 240.14a-12

 

BIOFRONTERA INC.

 

 

 

(Name of Registrant as Specified in Its Charter)

 

 

 

(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)

 

Payment of Filing Fee (check the appropriate box):

 

No fee required.
Fee paid previously with preliminary materials.
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

 

 

 

 

 

 

The following is a letter sent to certain shareholders of Biofrontera Inc. in a mailing commenced on November 29, 2022

 

 

Important Reminder To Vote Your Shares!

 

November 28, 2022

 

Dear Fellow Shareholder:

 

The annual meeting of Biofrontera Inc. (BFRI) is fast approaching and according to the latest records your shares are unvoted. Biofrontera Inc.’s Board of Directors is recommending that shareholders vote FOR on all the ballot items for our December 12th annual meeting.

 

Your vote and your voice as a shareholder is important to us. Please vote your shares in line with your Board’s recommendations today.

 

Your vote matters regardless of how many or how few shares you own. We need your voting support!

 

Please vote FOR:

 

Proposal 1: Election of Director Loretta M. Wedge
Proposal 2: Amend the 2021 Omnibus Stock Plan
Proposal 3: Ratify Grant Thornton LLP as Auditors

 

If you have any questions or need assistance with the voting of your shares, please contact our proxy advisor Alliance Advisors toll-free at: 1-844-717-2301 (inside the United States)/1-551-210-9857 (outside the United States)

 

Please vote today by using one of the methods indicated on the enclosed voting instruction form (VIF).

 

Thank you for your investment in Biofrontera Inc. and thank you for your vote.

 

Sincerely,

 

 

Erica Monaco, CEO

 

Biofrontera Inc.. 120 Presidential Way, Suite 330 . Woburn, MA 01801 . USAPage 1 of 1
Contact Phone +1 781 245 1325 . Email info-us@biofrontera.com . www.biofrontera-us.com 

 

GRAPHIC 2 formdefa14a_001.jpg begin 644 formdefa14a_001.jpg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formdefa14a_002.jpg begin 644 formdefa14a_002.jpg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end